Mon, March 25, 2024
Fri, March 22, 2024
Thu, March 21, 2024
Wed, March 20, 2024
Tue, March 19, 2024

Bill Maughan Reiterated (BNTX) at Strong Buy and Held Target at $171 on, Mar 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-171-on-mar-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Bill Maughan of Canaccord Genuity, Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $171 on, Mar 21st, 2024.

Bill has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 1 agrees with Bill's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024


These are the ratings of the 2 analyists that currently disagree with Bill


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $107 on, Tuesday, January 23rd, 2024
  • Jessica Fye of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $99 on, Friday, December 1st, 2023

Publication Contributing Sources